Stereotaxis Showcases Robotic Innovations at HRX Congress
Stereotaxis (NYSE: STXS), a frontrunner in surgical robotics for minimally invasive endovascular procedures, is excited to present its innovative technology at the upcoming HRX digital health conference. This important event is scheduled for September 5-7 and will focus on advancements in cardiovascular medicine.
Understanding the Heart Rhythm Society (HRX) Initiative
The HRX initiative, organized by the esteemed Heart Rhythm Society, highlights the progress in digital health. Its mission is to investigate cutting-edge technologies that aim to enhance cardiovascular care, making it more efficient and accessible to patients.
Insightful Presentations from Stereotaxis Leadership
David Fischel, the CEO of Stereotaxis, will spearhead discussions that focus on the future of electrophysiology labs. On September 5, he will lead a roundtable titled “The EP Lab of the Future.” Furthermore, on September 6, he will participate in a panel with distinguished experts, including Dr. Ben D'Souza and Dr. Dan Cooper, to discuss “The Role of Robotics in Present and Future Care of Heart Rhythm Patients.” Their involvement highlights the increasing significance of robotic technology in improving patient care and outcomes in the management of cardiac rhythms.
David Fischel's Insights
Fischel expressed his appreciation for the chance to connect with the HRX community, stating, “These discussions help us envision a future where patients and healthcare providers benefit from robotics, connectivity, and digital innovations.”
About Stereotaxis
Stereotaxis is recognized as a pioneer in robotic surgical systems designed for minimally invasive treatments. The company is committed to discovering, developing, and delivering cutting-edge robotic systems and solutions specifically for interventional labs. Their advanced technologies enhance patient care by facilitating precise and safe interventions, expanding access to minimally invasive therapies, and improving productivity in surgical settings. With a commendable history, Stereotaxis technology has effectively treated over 100,000 patients across various regions worldwide.
Contact Information for Stereotaxis
If you have further questions, please feel free to reach out to:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
Phone: 314-678-6100
Email: Investors@Stereotaxis.com
Frequently Asked Questions
What is the HRX Congress?
The HRX Congress is a digital health conference organized by the Heart Rhythm Society to explore innovative technologies in cardiovascular medicine.
Who is speaking at the Stereotaxis sessions?
David Fischel, along with experts like Dr. Ben D'Souza and Dr. Dan Cooper, will participate in discussions on cardiac robotic technology.
What technologies does Stereotaxis specialize in?
Stereotaxis specializes in robotic surgical systems for minimally invasive endovascular interventions, enhancing patient care and treatment outcomes.
How many patients has Stereotaxis technology treated?
Stereotaxis technology has successfully treated over 100,000 patients worldwide.
How can I contact Stereotaxis for more information?
You can contact Stereotaxis via phone at 314-678-6100 or email at Investors@Stereotaxis.com.